The 20 Best Ocular Hypertension (OHT) Doctors Near Me in Towson, MD

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal. Dr. Ramulu is board certified in American Board Of Ophthalmology.

Dr. Harry A. Quigley is the A. Edward Maumenee Professor of Ophthalmology and developed the Glaucoma Division at the Johns Hopkins Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for 8 years as its Secretary and was elected to 5 year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and editor-in-chief of Investigative Ophthalmology and Visual Science. He has published over 350 peer-reviewed articles, and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity and progression rate of glaucoma and other eye disease in American, African, Asian and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats and mice. Dr. Quigley is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy. Dr. Quigley is board certified in American Board Of Ophthalmology.

Dr. Hammond is an Assistant Professor of Psychiatry at Johns Hopkins University Department of Psychiatry with a joint appointment in the Division of Child & Adolescent Psychiatry and Behavioral Sciences and the Behavioral Pharmacology Research Unit (Affiliate). He completed his M.D. at University of Florida and his Ph.D. and residency/fellowship training at Yale University. Dr. Hammond’s research program focuses on characterizing the neurobiological predictors and mechanisms of treatment response for adolescent substance use disorders (SUDs) using multimodal neuroimaging (MRI, EEG) and large-scale brain network analytic approaches. His research is funded by a NIDA/AACAP Career Development Award (K12DA000357). Dr. Hammond’s research group is embedded in a larger collaborative research network within Johns Hopkin University School of Medicine applying translational neuroscience, clinical, and epidemiological methods to improve our understanding of brain-behavior relationships for youth suffering from substance use and mental health problems and aid in designing better evidence-based interventions. Clinically, Dr. Hammond works with youth (ages 13-25) with co-occurring substance use and psychiatric disorders in his role as Medical Director of the Co-occurring Disorders in Adolescents and Young Adults (CODA) Clinic at Johns Hopkins. He currently serves on the AACAP’s Substance Abuse and Addictions Committee and the American Academy of Addiction Psychiatry’s Youth and Adolescent Addiction Treatment Committee. Dr. Hammond is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ocular Hypertension (OHT), Blue Cone Monochromatism, Dementia, Vitrectomy, and Trabeculectomy. Dr. Hammond is board certified in American Board Of Psychiatry And Neurology.

Alan Robin is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Robin is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Cataract Removal, and Trabeculectomy.

Henry D. Jampel, M.D., M.H.S., is the Odd Fellows Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in glaucoma and serves as the medical director of Wilmer's Green Spring Station location. His research interests include evaluation of medical vs. surgical treatment of glaucoma in newly diagnosed patients and on imaging devices for the detection of glaucoma and its progression. Dr. Jampel received his M.D. degree from Yale University and his M.H.S. in health finance and management from the Johns Hopkins Bloomberg School of Public Health. He completed an internship in internal medicine at Sinai Hospital and his residency in ophthalmology at the Wilmer Eye Institute. After completing a glaucoma fellowship in glaucoma at Wilmer, Dr. Jampel joined the faculty in 1988. Dr. Jampel is rated as a Distinguished provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal. Dr. Jampel is board certified in American Board Of Ophthalmology.

Osamah Saeedi is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Saeedi is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Retinopathy of Prematurity, Cataract Removal, and Trabeculectomy.

Gail Schwartz is an Ophthalmologist practicing medicine in Towson, Maryland. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Cataract, and Trabeculectomy.

Marcos Doxanas is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Doxanas is rated as a Distinguished provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Dry Eye Syndrome, Chalazion, Eyelid Bump, and Cataract.

Everardo Hernandez-Quintela, M.D., M.Sc., F.A.C.S. is an accomplished cataract and cornea surgeon at the Wilmer Eye Institute’s locations in Baltimore and Lutherville, Maryland. He specializes in both refractive surgery (LASIK and PRK) and corneal transplant. Dr. Hernández-Quintela is the medical director for Wilmer's Patient Access Center for the Eye (PACE). Prior to joining Johns Hopkins Medicine, Dr. Hernandez Quintela was a professor of ophthalmology at the Universidad Nacional Autónoma de México where he led the course on research methodology in ophthalmology and the advanced course on cornea and refractive surgery. He is the founder of the international chapter of the Association of Research in Vision and Ophthalmology (ARVO) in Mexico, known as Colegio Nacional de Investigación en Ciencias Visuales (MARVO). Dr. Hernández-Quintela is a peer review editorial member of the Journal of the American Academy of Ophthalmology and the International Journal of Ophthalmology among other prestigious journals. He held a clinical academic position as head of cornea and refractive surgery services, and head of research at the Asociación para Evitar la Ceguera en México Hospital in Mexico City, which is one of the largest eye hospitals in Latin America. Dr. Hernández-Quintela began his career at Universidad La Salle and Universidad Nacional Autonoma de Mexico in Mexico City. He performed his residency training at the Asociación para Evitar la Ceguera en México Hospital, in Mexico City, and completed his fellowships at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in the United States with professor Dimitri Azar, and at the Hôtel Dieu Hospital, at Université Paris in France with Professor J.M. Legeais and Prof. Yves Pouliquen.Dr. Hernández-Quintela holds a Master in Science from the Universidad Nacional Autónoma de México, School of Medicine. Dr. Hernandez is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His clinical expertise encompasses Cataract, Optic Nerve Atrophy, Optic Atrophy Type 1, and Blepharitis.

"Oliver Schein, M.D., M.P.H., is the Burton E. Grossman Professor of Ophthalmology at the Wilmer Eye Institute and carries a joint appointment in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Dr. Schein's clinical expertise is in medical and surgical conditions of the anterior segment of the eye including cataract and complications of cataract surgery, corneal scarring and corneal surgery. He is a past author of the American Academy of Ophthalmology's ""Preferred Practice Pattern"" on Cataract. Research activities are directed toward the epidemiology of major ocular diseases, ophthalmic technology assessment and outcomes research in ophthalmology. Dr. Schein received his M.D. and M.P.H. degrees from Johns Hopkins University and completed his ophthalmology residency and cornea and external eye disease fellowship at Harvard University's Massachusetts Eye and Ear Infirmary. He joined the Wilmer faculty in 1988.". Dr. Schein is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cataract, Endophthalmitis, Fuchs Dystrophy, Cataract Removal, and Vitrectomy. Dr. Schein is board certified in American Board Of Ophthalmology and American Board Of Internal Medicine.

Sezen Karakus, M.D., is an assistant professor of ophthalmology specializing in corneal and external eye diseases, with a particular focus on ocular surface conditions in patients with autoimmune and inflammatory disorders such as Sjögren's syndrome and ocular rosacea. Her expertise also extends to corneal diseases involving abnormal sensory nerves, such as neurotrophic keratitis and neuropathic corneal pain. She is skilled in performing routine and complex procedures, including cataract and intraocular lens surgeries, refractive surgeries, corneal transplants, ocular surface reconstructions and amniotic membrane transplantations. At the Wilmer Eye Institute, Johns Hopkins Medicine's Ocular Surface Diseases and Dry Eye Clinic, she plays an integral role as a team member, providing her clinical insights and expertise. Additionally, she serves as an ophthalmologist in the Postural Orthostatic Tachycardia Syndrome (POTS) program at Hopkins. This unique position allows her to address dysautonomia-related neuropathic eye pain and ocular surface diseases in patients with POTS, combining her eye specialization with a focus on this specific medical condition. As a clinician-scientist, her research revolves around ocular surface diseases. Dr. Karakus is actively investigating the role of the ocular surface microbiome in the pathogenesis of ocular rosacea. Her involvement in the NIH U24 Ocular Surface Microbiome Consortium allows her to collaborate with fellow experts in the field to standardize research methrods and develop validated protocols for studying the ocular surface microbiome. Another area of research interest for Dr. Karakus involves serological and tear biomarkers in Sjögren's disease. Through a longitudinal study, she aims to determine the utility of tissue-specific autoantibodies for early diagnosis of Sjögren's disease in patients with dry eyes. Understanding the broader impact of Sjögren's disease on the peripheral and central nervous systems is crucial, as it can manifest as severe ocular surface disease with diminished corneal sensation (neurotrophic keratitis) or intense eye pain without significant ocular surface disease (neuropathic corneal pain). Her clinical expertise and research contributions have earned Dr. Karakus recognition regionally and nationally, as evidenced by her role as a consultant in complex dry eye and ocular surface diseases. She takes pride in her dedication to advancing the understanding of ocular surface conditions and providing the best possible care for patients. By combining her specialization in corneal and external eye disease with her involvement in the POTS program and cutting-edge research on ocular surface diseases, Dr. Karakus strives to make a significant impact on patient care and contribute to the advancement of ophthalmology and related fields. Dr. Karakus is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Dry Eye Syndrome, Sjogren Syndrome, Cataract, Conjunctivitis (Pink Eye), and Corneal Transplant.

Uri S. Soiberman, M.D. joined Wilmer's Cornea faculty in 2016, and is an associate professor of ophthalmology and the director of the cornea fellowship at the Wilmer Eye Institute. Dr. Soiberman's main clinical and research focus is keratoconus, and his research has been funded by the National Eye Institute and Research to Prevent Blindness. Dr. Soiberman offers his keratoconus patients advanced surgical treatments, including corneal collagen crosslinking, deep anterior lamellar keratoplasty and other types of corneal transplants for keratoconus. Dr. Soiberman also performs endothelial keratoplasty (DSEK, DMEK, DSO) for patients with Fuchs endothelial dystrophy and corneal edema. In addition, Dr. Soiberman specializes in complex cataract surgery, and offers his patients specialty intraocular lenses (such as astigmatism correcting or multifocal lenses). His surgical acumen includes surgery for dislocated lenses and secondary implantation of intraocular lenses. Dr. Soiberman is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Keratoconus, Cataract, Interstitial Keratitis, Corneal Transplant, and Vitrectomy. Dr. Soiberman is board certified in American Board Of Ophthalmology.

Raya Armaly is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Armaly is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Blepharitis, and Optic Nerve Atrophy.

Donna Booth is an Ophthalmologist practicing medicine in Lutherville Timonium, Maryland. Dr. Booth is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cataract, Dry Eye Syndrome, Glaucoma, and Ocular Hypertension (OHT).

Amy Zimmerman is an Ophthalmologist practicing medicine in Lutherville Timonium, Maryland. Dr. Zimmerman is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Cataract, Interstitial Keratitis, Glaucoma, and Subconjunctival Hemorrhage.

Katherine Fallano is an Ophthalmologist practicing medicine in Towson, Maryland. Dr. Fallano is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Cataract, Ocular Hypertension (OHT), Neuroretinitis, and Trabeculectomy.

Katherine Duncan is an Ophthalmologist practicing medicine in Towson, Maryland. Dr. Duncan is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Chalazion, Eyelid Bump, Meibomianitis, and Cataract.

Erica Bernfeld is an Ophthalmologist practicing medicine in Lutherville, Maryland. Dr. Bernfeld is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Cataract, Glaucoma, Dry Eye Syndrome, and Blepharitis.

Clare Kelliher is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Kelliher is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Cataract, Glaucoma, Fuchs Dystrophy, and Macular Corneal Dystrophy Type 1.

Donald Abrams is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Abrams is rated as an Advanced provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Cataract, Blepharitis, and Dry Eye Syndrome.